Pharmaserv Logistics Creates a "Central Pharmaceutical Distribution Center"

Pharmaserv Logistics Central Pharmaceutical Distribution Centre currently under...
Pharmaserv Logistics' "Central Pharmaceutical Distribution Centre" currently under construction

Pharmaserv Logistics, the contract logistics service provider specializing in the pharmaceutical and biotech sectors, is expanding its existing GMP warehouse capacity at its Behringwerke site in Marburg, Germany.

A further new extension will complete the expansion to create a "Central Pharmaceutical Distribution Centre" by late 2015. From 2016 onwards, additional new customers in the pharmaceutical, biotech and medical care sectors will be serviced from there. Different temperature ranges are now available to customers for the storage, handling and distribution of pharmaceutical productions – naturally all GMP and GDP-compliant.

Pharmaserv Logistics' new build enables the service provider to meet the rising demand for specialist logistics services for sensitive and temperature-controlled drugs. The central distribution center concept also efficiently supports international pharmaceutical customers in their efforts to penetrate and supply the European market.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.